C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/24 (2006.01) A61K 31/7088 (2006.01) A61K 38/18 (2006.01) A61K 38/20 (2006.01) A61K 48/00 (2006.01) C07K 14/475 (2006.01) C07K 14/54 (2006.01) C07K 16/22 (2006.01) C07K 16/24 (2006.01) C07K 19/00 (2006.01) C12N 5/10 (2006.01) C12N 15/18 (2006.01) C12N 15/62 (2006.01) C12N 15/63 (2006.01) C12P 21/02 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2454578
Modified, furin resistant human TSLP polypeptides and polynucleotides encoding the modified human TSLP polypeptides are provided. Pharmaceutical compositions, B and T cell activation agents, assays and methods of use are also described.
L'invention concerne des polypeptides TSLP humains modifiés, résistant à la furine, et des polynucléotides codant ces polypeptides. L'invention concerne également des compositions pharmaceutiques, des activateurs de lymphocytes B et T, des tests, et des procédés d'utilisation correspondants.
Lyman Stewart D.
Paxton Raymond J.
Van Ness Kirk P.
Immunex Corporation
Smart & Biggar
LandOfFree
Modified human thymic stromal lymphopoietin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified human thymic stromal lymphopoietin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified human thymic stromal lymphopoietin will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1916475